CRL (CRL) insider files Form 144 for potential 5,046-share sale

Rhea-AI Filing Summary

CRL has a Form 144 notice indicating a potential sale of up to 5,046 shares of common stock on the NYSE, with an aggregate market value of $1,327,098.00. The filing lists total common shares outstanding of 47,738,872. The sale, proposed for 08/05/2026, includes shares from performance stock awards granted on 01/27/2023 (3,511 shares) and 01/29/2024 (1,535 shares) by the issuer.

Key Figures

Shares to be sold: 5,046 shares Aggregate market value: $1,327,098.00 Shares outstanding: 47,738,872 shares +2 more

5 metrics

Shares to be sold 5,046 shares Maximum common shares covered by Form 144 notice

Aggregate market value $1,327,098.00 Value assigned to 5,046 shares to be sold

Shares outstanding 47,738,872 shares Total common shares outstanding referenced in Form 144

Performance award shares 2023 grant 3,511 shares Shares from performance stock award granted 01/27/2023

Performance award shares 2024 grant 1,535 shares Shares from performance stock award granted 01/29/2024

Key Terms

Form 144, Performance Stock Award, aggregate market value

3 terms

Form 144 regulatory

"CRL has a Form 144 notice indicating a potential sale"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Stock Award financial

"includes shares from performance stock awards granted on 01/27/2023"

aggregate market value financial

"with an aggregate market value of $1,327,098.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 04:03 PM Accepted by SEC EDGAR 08/05/2026 - 04:02 PM Learn about SEC filing dates

FAQ

What does the Form 144 filed for CRL indicate?

The Form 144 for CRL indicates an intention to sell up to 5,046 common shares on the NYSE, with an aggregate market value of $1,327,098.00, subject to applicable conditions and timing.

How many CRL shares are covered by the Form 144 notice?

The Form 144 covers up to 5,046 CRL common shares. This includes shares tied to performance stock awards granted in 2023 and 2024, which may be sold on or after 08/05/2026.

What is the aggregate market value of CRL shares in this Form 144?

The potential sale has an aggregate market value of $1,327,098.00. This figure reflects the value assigned in the Form 144 for the 5,046 common shares that may be sold on the NYSE.

How many CRL shares are outstanding according to this Form 144?

The Form 144 states that 47,738,872 CRL common shares are outstanding. This figure provides context for the potential 5,046-share sale, which represents only a small portion of the total shares.

What performance stock awards are referenced in CRL’s Form 144?

The notice references performance stock awards granted on 01/27/2023 for 3,511 shares and on 01/29/2024 for 1,535 shares, each by the issuer, which form part of the shares that may be sold.

When could the CRL shares in this Form 144 be sold?

The Form 144 lists a proposed sale date of 08/05/2026. This date reflects when the filer anticipates selling the 5,046 common shares, subject to market conditions and regulatory requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc 11 Madison Ave 4th Floor New York NY 10010	5046	1327098.00	47738872	08/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2023	Performance Stock Award	Issuer			3511	01/27/2023	N/A
Common	01/29/2024	Performance Stock Award	Issuer			1535	01/29/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)